How successful was Prolift surgery for genital prolapse in a small series of women, and what complications occurred?

Details

This descriptive surgical case series evaluated the feasibility and short-term efficacy of Prolift® transvaginal reinforcement for genital prolapse, along with intraoperative and postoperative complications. Eleven women underwent the procedure in the urology department of Auxerre Hospital.

The investigators recorded gynecological and obstetric characteristics, risk factors, previous treatments, associated procedures, and intraoperative and postoperative complications. Follow-up visits were scheduled at one, three, and six months, then annually. Failure was defined as recurrence at stage I or higher on the Baden and Walker classification.

The mean age was 70 years, and median follow-up was 9 months. Two women (18%) had grade II cystocele and nine (81%) had grade III cystocele. Five women (45%) had grade II/III rectocele, and three (27%) had uterine prolapse (hysterocele).

Mean operating time was 40 minutes, and hospital stay was 3 days. No intraoperative complications were reported. Postoperative complications included three cases of cystitis, one vaginal erosion (9%) treated by excision of the exposed portion, one case of new-onset stress urinary incontinence (9%), and two cases of urinary urgency (18%).

The reported success rate was 90%. The authors concluded that Prolift® was feasible and effective in the short term for genital prolapse, with morbidity they considered acceptable.